Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction

GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others” provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Inhalation Systems, Needle Free Injections and Infusion Systems. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Inhalation Systems, Needle Free Injections and Infusion Systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others.
- 2009 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Canada Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Sepracor Inc., CareFusion Corporation and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Explore investment opportunites in the market.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
GlaxoSmithKline plc
AstraZeneca PLC
Sepracor Inc.
Boehringer Ingelheim GmbH
CareFusion Corporation
3M Health Care
Smiths Medical
B. Braun Melsungen AG
Bioject Medical Technologies Inc.
Baxter International Inc.
Hospira, Inc.
Terumo Corporation
Novartis Medical Nutrition
Antares Pharma, Inc.
NIPRO CORPORATION
Fresenius Kabi AG
Cardinal Health, Inc.
[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What is This Report About? 10
3 Drug Delivery Devices In Canada 11
3.1 Drug Delivery Devices, Market Segmentation 11
3.2 Drug Delivery Devices, Canada, Overall Revenue ($m), 2002-2016 12
3.3 Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2009 14
3.4 Drug Delivery Devices Market, Canada, Category Contribution (%), 2009 15
3.5 Drug Delivery Devices, Canada, Category Volume (Units), 2002-2016 21
3.6 Drug Delivery Devices, Canada, Company Share (2008-2009) 26
4 Infusion Systems In Canada 28
4.1 Infusion Systems, Market Segmentation 28
4.2 Infusion Systems Market, Canada, Revenue Mix ($m), 2009 29
4.3 Infusion Systems Market, Canada, Category Contribution (%), 2009 30
4.4 Infusion Systems Overall Revenue (2002-2016) 31
4.5 Infusion Systems Overall Volume (2002-2016) 35
4.6 Infusion Systems Average Price (2002-2016) 39
4.7 Infusion Systems Distribution Share (2008-2009) 40
4.8 Infusion Systems, Canada, Company Share (2008-2009) 41
5 Inhalation Systems In Canada 43
5.1 Inhalation Systems, Market Segmentation 43
5.2 Inhalation Systems Market, Canada, Revenue Mix ($m), 2009 44
5.3 Inhalation Systems Market, Canada, Category Contribution (%), 2009 45
5.4 Inhalation Systems Overall Revenue (2002-2016) 46
5.5 Inhalation Systems Overall Volume (2002-2016) 50
5.6 Inhalation Systems Average Price (2002-2016) 52
5.7 Inhalation Systems Distribution Share (2008-2009) 53
5.8 Inhalation Systems, Canada, Company Share (2008-2009) 54
6 Needle Free Injections In Canada 56
6.1 Needle Free Injections Overall Revenue (2002-2016) 56
6.2 Needle Free Injections Overall Volume (2002-2016) 58
6.3 Needle Free Injections Average Price (2002-2016) 60
6.4 Needle Free Injections Distribution Share (2008-2009) 61
6.5 Needle Free Injections, Canada, Company Share (2008-2009) 62
7 Overview of Key Companies in Canada Drug Delivery Devices Market 63
7.1 GlaxoSmithKline plc 63
7.1.1 Company Overview 63
7.1.2 Share in the Canada Drug Delivery Devices Market 63
7.2 AstraZeneca PLC 64
7.2.1 Company Overview 64
7.2.2 Share in the Canada Drug Delivery Devices Market 65
7.3 Sepracor Inc. 66
7.3.1 Company Overview 66
7.3.2 Share in the Canada Drug Delivery Devices Market 66
7.4 Boehringer Ingelheim GmbH 67
7.4.1 Company Overview 67
7.4.2 Share in the Canada Drug Delivery Devices Market 67
7.5 CareFusion Corporation 68
7.5.1 Company Overview 68
7.5.2 Share in the Canada Drug Delivery Devices Market 68
7.6 3M Health Care 69
7.6.1 Company Overview 69
7.6.2 Share in the Canada Drug Delivery Devices Market 69
7.7 Smiths Medical 70
7.7.1 Company Overview 70
7.8 B. Braun Melsungen AG 70
7.8.1 Company Overview 70
7.9 Bioject Medical Technologies Inc. 70
7.9.1 Company Overview 70
7.10 Baxter International Inc. 71
7.10.1 Company Overview 71
7.11 Hospira, Inc. 71
7.11.1 Company Overview 71
7.12 Terumo Corporation 71
7.12.1 Company Overview 71
7.13 Novartis Medical Nutrition 72
7.13.1 Company Overview 72
7.14 Antares Pharma, Inc. 72
7.14.1 Company Overview 72
7.15 NIPRO CORPORATION 73
7.15.1 Company Overview 73
7.16 Fresenius Kabi AG 73
7.16.1 Company Overview 73
7.17 Cardinal Health, Inc. 73
7.17.1 Company Overview 73
8 Drug Delivery Devices Market Pipeline Products 74
9 Financial Deals Landscape 80
9.1 Partnerships 80
9.1.1 Anesiva Terminates Its License And Distribution Agreement With Medical Futures 80
9.1.2 iCo Therapeutics Signs Research Agreement With Consortium for Parasitic Drug Development 81
10 Recent Developments 82
10.1 Strategy and Business Planning 82
10.1.1 Feb 01, 2010: Pyng Medical Opens Sales Office In Washington 82
10.1.2 Dec 01, 2009: Sanofi-Aventis Canada Signs Licensing Agreement With Intelliject 82
10.1.3 Sep 02, 2009: Generex Launches European Subsidiary 82
10.2 Product News 84
10.2.1 Jun 25, 2009: Maximus Presents MaxPlus Clear At Infusion Nursing Society Annual Conference 84
11 Appendix 85
11.1 Definitions of Markets Covered in the Report 86
11.1.1 Drug Delivery Devices 86
11.2 Research Methodology 87
11.3 Secondary Research 87
11.4 Primary Research 88
11.5 Models 88
11.6 Forecasts 88
11.7 Expert Panels 89
11.8 GlobalData Consulting 89
11.9 Currency Conversion 89
11.10 Contact Us 89
11.11 Disclaimer 90
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Drug Delivery Devices, Canada, Overall Revenue ($m), 2002-2016 13
Table 2: Drug Delivery Devices Market, Canada, Category Contribution (%), 2009 15
Table 3: Drug Delivery Devices, Canada Cross-Category Analysis, 2002-2016 16
Table 4: Drug Delivery Devices, Canada, Overall Revenue ($m), Historic, 2002-2009 18
Table 5: Drug Delivery Devices, Canada, Overall Revenue ($m), Forecast, 2009-2016 20
Table 6: Drug Delivery Devices, Canada, Category Volume (Units), 2002-2016 21
Table 7: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2002-2009 23
Table 8: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2009-2016 25
Table 9: Drug Delivery Devices, Canada, Company Share by Revenue ($m), 2008-2009 27
Table 10: Infusion Systems Market, Canada, Category Contribution (%), 2009 30
Table 11: Infusion Systems, Canada, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 12: Infusion Systems, Canada, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 13: Infusion Systems, Canada, Volume (Units) by Segment, Historic, 2002-2009 36
Table 14: Infusion Systems, Canada, Volume (Units) by Segment, Forecast, 2009-2016 38
Table 15: Infusion Systems, Canada, Average Price ($), Historic, 2002-2009 39
Table 16: Infusion Systems, Canada, Average Price ($), Forecast, 2009-2016 39
Table 17: Infusion Systems, Canada, Distribution Share by Revenue ($m), 2008-2009 40
Table 18: Infusion Systems, Canada, Company Share by Revenue ($m), 2008-2009 42
Table 19: Inhalation Systems Market, Canada, Category Contribution (%), 2009 45
Table 20: Inhalation Systems, Canada, Revenue ($m) by Segment, Historic, 2002-2009 47
Table 21: Inhalation Systems, Canada, Revenue ($m) by Segment, Forecast, 2009-2016 49
Table 22: Inhalation Systems, Canada, Volume (Units) by Segment, Historic, 2002-2009 50
Table 23: Inhalation Systems, Canada, Volume (Units) by Segment, Forecast, 2009-2016 51
Table 24: Inhalation Systems, Canada, Average Price ($), Historic, 2002-2009 52
Table 25: Inhalation Systems, Canada, Average Price ($), Forecast, 2009-2016 52
Table 26: Inhalation Systems, Canada, Distribution Share by Revenue ($m), 2008-2009 53
Table 27: Inhalation Systems, Canada, Company Share by Revenue ($m), 2008-2009 55
Table 28: Needle Free Injections, Canada, Revenue ($m, Historic, 2002-2009 56
Table 29: Needle Free Injections, Canada, Revenue ($m), Forecast, 2009-2016 57
Table 30: Needle Free Injections, Canada, Volume (Units), Historic, 2002-2009 58
Table 31: Needle Free Injections, Canada, Volume (Units), Forecast, 2009-2016 59
Table 32: Needle Free Injections, Canada, Average Price ($), Historic, 2002-2009 60
Table 33: Needle Free Injections, Canada, Average Price ($), Forecast, 2009-2016 60
Table 34: Needle Free Injections, Canada, Distribution Share by Revenue ($m), 2008-2009 61
Table 35: Needle Free Injections, Canada, Company Share by Revenue ($m), 2008-2009 62
Table 36: Drug Delivery Devices Market Pipeline Products 74
Table 37: Anesiva Terminates Its License And Distribution Agreement With Medical Futures 80
Table 38: iCo Therapeutics Signs Research Agreement With Consortium for Parasitic Drug Development 81
Table 39: USD to Local Currency, Canada, Average Actual Rate 2002-2009 89
LIST OF FIGURES

1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 11
Figure 2: Drug Delivery Devices, Canada, Overall Revenue ($m), 2002-2016 12
Figure 3: Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2009 14
Figure 4: Drug Delivery Devices Market, Canada, Category Contribution (%), 2009 15
Figure 5: Drug Delivery Devices Market, Canada, Cross-Category Analysis, 2002-2016 16
Figure 6: Drug Delivery Devices, Canada, Overall Revenue ($m), Historic, 2002-2009 17
Figure 7: Drug Delivery Devices, Canada, Overall Revenue ($m), Forecast, 2009-2016 19
Figure 8: Drug Delivery Devices, Canada, Category Volume (Units), 2002-2016 21
Figure 9: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2002-2009 22
Figure 10: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2009-2016 24
Figure 11: Drug Delivery Devices, Canada, Company Share (%), 2009 26
Figure 12: Infusion Systems, Market Segmentation 28
Figure 13: Infusion Systems Market, Canada, Revenue Mix ($m), 2009 29
Figure 14: Infusion Systems Market, Canada, Category Contribution (%), 2009 30
Figure 15: Infusion Systems, Canada, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 16: Infusion Systems, Canada, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 17: Infusion Systems, Canada, Volume (Units) by Segment, Historic, 2002-2009 35
Figure 18: Infusion Systems, Canada, Volume (Units) by Segment, Forecast, 2009-2016 37
Figure 19: Infusion Systems, Canada, Company Share (%), 2009 41
Figure 20: Inhalation Systems, Market Segmentation 43
Figure 21: Inhalation Systems Market, Canada, Revenue Mix ($m), 2009 44
Figure 22: Inhalation Systems Market, Canada, Category Contribution (%), 2009 45
Figure 23: Inhalation Systems, Canada, Revenue ($m) by Segment, Historic, 2002-2009 46
Figure 24: Inhalation Systems, Canada, Revenue ($m) by Segment, Forecast, 2009-2016 48
Figure 25: Inhalation Systems, Canada, Volume (Units) by Segment, Historic, 2002-2009 50
Figure 26: Inhalation Systems, Canada, Volume (Units) by Segment, Forecast, 2009-2016 51
Figure 27: Inhalation Systems, Canada, Company Share (%), 2009 54
Figure 28: Needle Free Injections, Canada, Revenue ($m), Historic, 2002-2009 56
Figure 29: Needle Free Injections, Canada, Revenue ($m), Forecast, 2009-2016 57
Figure 30: Needle Free Injections, Canada, Volume (Units), Historic, 2002-2009 58
Figure 31: Needle Free Injections, Canada, Volume (Units), Forecast, 2009-2016 59
Figure 32: Needle Free Injections, Canada, Company Share (%), 2009 62
Figure 33: GlaxoSmithKline plc, Company Share (%),Canada Drug Delivery Devices Market, 2009 63
Figure 34: AstraZeneca PLC, Company Share (%),Canada Drug Delivery Devices Market, 2009 65
Figure 35: Sepracor Inc., Company Share (%),Canada Drug Delivery Devices Market, 2009 66
Figure 36: Boehringer Ingelheim GmbH, Company Share (%),Canada Drug Delivery Devices Market, 2009 67
Figure 37: CareFusion Corporation, Company Share (%),Canada Drug Delivery Devices Market, 2009 68
Figure 38: 3M Health Care, Company Share (%),Canada Drug Delivery Devices Market, 2009 69
[Tabellenverzeichnis ausblenden]